management team

Stephen Turner is Chief Executive Officer and Chairman of the Board, positions he has held since founding the company in July, 2001. From 1999 to 2001 he served as President and CEO of Quorum Sciences, Inc. From 1984 to 1997 he was President and CEO of Oncor, Inc. He founded Bethesda Research Laboratories, Inc. in 1975 and served as its Chairman and CEO from 1975 to 1983, at which time BRL became the molecular biology division of Life Technologies, Inc. Prior to commencing his career in biotechnology, Mr. Turner held the position of Director of Marketing for the Clinical Microbiology Division of Becton, Dickinson & Co. He received his B.A. from Stanford University in 1967. In 1994 he received the Ernst & Young Entrepreneur of the Year Award in Life Sciences for the Washington D.C. Region.

Matthew Powell, Ph.D. is Protea's Director, Research & Development and Chief Science Officer. He received his Ph.D. in Analytical Chemistry from West Virginia University in 2005. Dr. Powell's expertise is in the field of biological mass spectrometry and is a co-inventor of certain technologies developed by the Company. Dr. Powell has presented to several scientific talks and seminars to international audiences; most recently as a guest lecturer for AnalytiX 2013 in Suzhou, China

David Halverson is Protea’s President. Prior to his appointment as President, David served as Protea’s Vice President and Chief Business Officer. Before joining Protea, David was employed by Huntingdon Life Sciences in various capacities, including Head of European and US Sales. He has over 20 years of management experience in the pharmaceutical services industry, including serving as a Director of Sales for PPD Discovery and the Quintiles Preclinical Groups. 

Haddon Goodman
is Protea's Vice President of Corporate Development.  Prior to joining Protea, Haddon held various positions at Fisher Scientific in product management launching new products, managing strategic supplier relationships, and  planning/implementing marketing campaigns.  This experience combined with his background in biology enabled Haddon to operate in various product management, marketing, and business roles at Protea.  Today, Haddon is focused on driving Protea's innovative technologies and workflows through key collaborations and in licensing and out licensing opportunities







Visit our Resource Center to learn more about our technologies and capabilities.